Umbilical cord blood CD34+ hematopoietic stem cell-derived natural killer cells in Acute Myeloid Leukemia – a phase I clinical study
Michael Heuser(Martin Luther University Halle-Wittenberg), Adil Deniz Duru(Marmara University), Jakob Passweg(University Hospital of Basel), Letizia Venturini(Zimmer Biomet (Netherlands)), Arnold Ganser(Medizinische Hochschule Hannover), Anna‐Maria Georgoudaki, Monica Raimo(University of Turin), Adrian Schwarzer(Universitätsmedizin Greifswald), Didem Özkazanç(Hacettepe University Hospital), Jan Moritz Middeke(Fresenius (Germany)), Andreas Block(Universität Hamburg), Michael Stadler(Medizinische Hochschule Hannover), David de Leeuw, Felicitas Thol(Medizinische Hochschule Hannover), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Arjan van de Loosdrecht(Amsterdam University Medical Centers), Walter Fiedler(Universität Hamburg), Astrid Tschan‐Plessl(University Hospital of Basel), Isabell Arnhardt(Medizinische Hochschule Hannover), Arnold Kloos(Medizinische Hochschule Hannover), Amanda van Vliet, Eva-Maria Wagner Drouet(Johannes Gutenberg University Mainz), Virginie Bonnamain(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k